Biotech Business Week articles from September 2004

Biotech Business Week archives from September 2004

Pharmaceutical firm wins $13.1M biodefense research contract.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Caprion Pharmaceuticals, Inc., has been awarded a U.S. $13.1 million contract by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, to...

BNO69 angiogenesis gene discovery published in journal.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Bionomics Limited announced that research conducted by Bionomics and its collaborators at the Hanson Centre of the Institute of Medical and Veterinary Science (IMVS) in Adelaide, Australia, relating to...

$6.95 million NIH contract awarded for RVAD development.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The Cleveland Clinic department of biomedical engineering and Kiyotaka Fukamachi, MD, PhD, have been awarded a $6.95 million contract from the National Heart, Lung and Blood Institute to develop and...

Disposables/reusables dynamic affects disposable drapes and gowns markets.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The market for disposable surgical drapes and gowns in Europe has seen steady growth in the recent past owing to the high standards of infection control enforced by the new European Union Medical Device...

BLA submitted to FDA for Adacel vaccine.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Aventis (AVE) announced the submission of a Biologics Licensing Application (BLA) to the U.S. Food and Drug Administration (FDA) for marketing approval of Adacel (Tetanus Toxoid and Reduced Diphtheria...

Efficiency, productivity gains drive uptake of wireless healthcare applications.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The market for wireless healthcare applications in Europe is emerging rapidly, responding to technological changes. As hospitals head towards complete digitization of image management functions and...

Patient enrollment completed in phase I/II trial in AIDS.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that all 30 patients have been enrolled in its phase I/II clinical trial of AVR118 in patients with AIDS, thereby completing patient enrollment in this...

FDA clears MediLite for acne treatment.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Inner Act, a product development company based in Reno, recently received U.S. Food and Drug Administration (FDA) clearance for the treatment of acne with their MediLite LED product, effective July 27,...

First patients enter pivotal phase II study of clofarabine.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Bioenvision, Ltd., (BIV) has announced that the first adult patients have been dosed on a pivotal European phase II study to evaluate its lead leukemia compound, clofarabine, in the treatment of adults...

Federal report finds rural areas top urban in treatment for painkiller abuse.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A new report, "Treatment Admissions in Urban and Rural Areas Involving Abuse of Narcotic Painkillers: 2002 Update," released by the Substance Abuse and Mental Health Services Administration finds rural...

Pharma company announces equity investment in New River Pharmaceuticals.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Par Pharmaceutical Companies, Inc., (NYSE:PRX) announced the purchase of 875,000 shares of common stock of New River Pharmaceuticals Inc. (NASDAQ:NRPH) in New River's initial public offering. The...

Researchers find new hope for detecting gene doping.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers have discovered a new method for detecting gene doping in the blood, according to new research featured in the August issue of Molecular Therapy. Molecular Therapy is the official...

Biomarker study to identify unique metabolic signatures for ALS.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Metabolon, Inc., announced its collaboration with Massachusetts General Hospital on a new biomarker study funded by the National Institute of Neurological Disorders and Stroke (NINDS). Metabolon...

Aranesp receives positive regulatory opinion for extended dosing in Europe.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Amgen, Inc., (AMGN) announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to expand the marketing authorization for Aranesp (darbepoetin...

Company gets guidance from FDA on percutaneous procedure.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- CardioGenesis Corporation (CGCP), developer of surgical products and accessories used in angina-relieving Transmyocardial Revascularization (TMR) and Percutaneous Myocardial Revascularization (PMR)...

New technology helps protect New York City buildings from bio-weapons.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Financial institutions, key government buildings and hospitals are using a new technology for protection against terrorists using biological weapons. The technology safeguards against attacks in...

Biopharma company commences trading on the AIM Exchange.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Ondine Biopharma Corp. (TSX-V:OBP) (Ondine) announced that the company's common shares have commenced trading on the London Stock Exchange's Alternative Investment Market (AIM) under the Symbol "OBP."...

FDA approves ophthalmic anti-inflammatory/antibiotic combination product.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Pharmos Corp.'s (PARS) former marketing partner, Bausch & Lomb, has received from the U.S. Food and Drug Agency (FDA) an approvable letter for ZyLET, the new drug application which was filed by Bausch &...

New over-the-counter pain relieving cream launched.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Naturally Vitamins announced the launch of Wobenzym N Creme. Bearing the respected Wobenzym name, this soothing topical pain reliever is an important addition to Naturally's long-established...

Medical technology achieves 94% efficiency in treating atrial fibrillation.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- CryoCor, Inc., announced 94% acute efficacy for isolation of treated pulmonary veins from Robert H. Hoyt, MD, one of its principle investigators from the Iowa Heart Center in Des Moines, using CryoCor's...

Researchers develop a new in vivo atrial fibrillation model in rats.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Newly developed rat model of atrial fibrillation (AF) has several characteristics in common with humans. "Nonpharmacological in vivo models of atrial fibrillation (AF) have been developed in large...

FDA approves ADDERALL XR to treat ADHD in adults.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Shire Pharmaceuticals Group, plc, announced that the U.S. Food and Drug Administration (FDA) has approved ADDERALL XR (mixed salts of a single-entity amphetamine) as a once-daily treatment for adults...

Benign prostatic hyperplasia clinical trial sties selected.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced that most of the United States centers have been selected for the multicenter prostate Phase 2 study of NX-1207, the company's investigational...

Automatic methods devised for analyzing chemical shift perturbation NMR spectra.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Several novel techniques have been devised for automatic analysis of nuclear magnetic resonance (NMR) imaging results. Researchers in California presented "new methods designed for quantitative...

Diffraction biosensor monitors interaction of molecules in a label-free way.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Surface plasmon-enhanced diffraction is being used for label-free biosensing. Investigators in Germany report, "Surface plasmon-enhanced evanescent field at a (noble) metal/dielectric interface can...

Handheld probe is useful for detecting degenerative changes in joints.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A handheld indentation probe has been used to demonstrate a correlation of cartilage stiffness to thickness and level of degeneration. "The in vivo assessment of the quality of cartilage is a...

"Hold-and-flush" method improves fluid chromatography fraction collection.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A novel "hold-and-flush" technique can improve collection of fluid chromatography fractions. "In supercritical fluid chromatography, the partial phase separation that occurs in the dead volume...

microRNAs quantitated using a modified Invader assay.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- microRNAs were quantitated using a modified Invader assay. According to a study from the United States, "The short lengths of microRNAs (miRNAs) present a significant challenge for detection and...

Company receives $16.4M contract to redesign chemical/biological shelter unit.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Engineered Support Systems, Inc., (EASI) has received a new contract for $16.4 million from the U.S. Army for production of a next-generation, electronic-powered chemical biological protective shelter...

ClearStep "invisible" braces launched in the U.K.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- ClearStep, an invisible orthodontic brace, is being launched in the UK. The brace has been developed by Dr. Andrew McCance, a specialist, orthodontists, and a team of technicians from two teaching...

New breast cancer clinical trial program commences.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Two new multicenter studies to evaluate Bioenvision's (BIV) Modrenal (trilostane), in pre- and post-menopausal forms of breast cancer, were announced. The phase II (pre-menopausal) and phase IV...

Patent application filed for TamoGel for treatment of benign breast disease.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Ascend Therapeutics has filed a patent application for both the pharmaceutical composition of TamoGel (4-hydroxytamoxifen gel) and the gel's use for the treatment of benign breast disease. The...

Antioxidant maker reports loss of $0.81 per share.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Aeolus Pharmaceuticals, Inc., (AOLS) announced the financial results for its third quarter of fiscal 2004, the 3-month period ended June 30, 2004. The company also reviewed recent events regarding...

Biopharmaceutical company announces 32% revenue increase for second quarter 2004.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Novavax, Inc., (NASDAQ:NVAX) announced its financial results for the second quarter ended June 30, 2004. Total revenues for the second quarter rose 32% to $3.0 million compared to second quarter...

Biopharmaceutical company reports improved first quarter financial results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Repligen Corporation (NASDAQ:RGEN) reported results for the first quarter of fiscal year 2005 ended June 30, 2004. Total revenue for the quarter was $2,809,000 compared to total revenue of...

Cardiac device maker reports finances, business plan.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- CardioTech International, Inc., reports revenue of $5,531,000 for the quarter ended June 30, 2004. For the 3 months ended June 30, 2004, the company generated $73,000 of income from operations,...

Chemical company to raise prices for hydrogen peroxide.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Solvay Chemicals Inc. will increase off-list prices for all grades of hydrogen peroxide. Prices will increase $0.05 per pound in the U.S. and $150 per metric ton in Canada for 100% basis hydrogen...

Cor Equity Holdings completes public spin-off.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Cor Equity Holdings, Inc.. (CEQH), announced that it has successfully completed the spin-off of its subsidiary, Medical Home Products, Inc. The trading symbol for the new public entity is MHPD. ...

Dialysis chain reports second-quarter net income of $52.4 million.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- DaVita, Inc., (DVA) announced results for the quarter ended June 30, 2004. Net income for the 3 months and 6 months ended June 30, 2004 was $52.4 million and $105.3 million, or $0.50 and $1.02 per...

Drug delivery developer reports quarterly finances, clinical pipeline update.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Acusphere, Inc., (ACUS) reported financial results for the second quarter ended June 30, 2004, and commented on its operational progress. The company's financial results for the second quarter of...

Fuzeon maker reports strong Q4 and year-end results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Chronimed, Inc., (CHMD) reported record revenue and earnings for the fourth quarter and year ended July 2, 2004. Total reported company revenue for the 14-week quarter ending July 2, 2004 was a...

Genta announces second-quarter 2004 financial results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Genta, Inc., (GNTA) announced financial results for the second quarter ended June 30, 2004. The company reported revenues of $1.6 million for the quarter, and a net loss of $29.2 million or $0.37...

Healthcare IT firm reports guidance in range of $29-31M.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Bio-Imaging Technologies, Inc., (BITI), announced its financial results for the second ended June 30, 2004. Mark L. Weinstein, president and CEO of Bio-Imaging, said, "We are pleased that during he...

Healthcare sales and marketing company reports strong second quarter performance.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- PDI, Inc., (NASDAQ:PDII), a healthcare sales and marketing company, announced its second quarter 2004 financial results. Net revenue for the quarter ended June 30, 2004, was $83.2 million, 16.8%...

MS drug maker reports loss of $0.02 per share.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- AutoImmune, Inc., (AIMM) reported a net loss of $0.30 million, or $0.02 per share basic and diluted, for the 3 months ended June 30, 2004, compared with net loss of $0.14 million, or $0.01 per share...

Pharma company reports successful results for the second quarter 2004.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- NitroMed, Inc., (NASDAQ: NTMD) reported financial results for the second quarter ended June 30, 2004. The company also reported on recent corporate achievements, including the early halt to its...

Pharmaceutical company announces 41% second quarter revenue increase.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Questcor Pharmaceuticals, Inc., (AMEX:QSC) announced financial results for the quarter and 6 months ended June 30, 2004. Total revenue for the second quarter of 2004 was $4,090,000, up 41% from...

Pharmaceutical company launches share buy-back program.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Novartis AG (NYSE: NVS) announced that its board of directors has decided to launch a new share repurchase program for up to CHF 3 billion following the completion of a program initiated in 2002. ...

Pharmaceutical company reports fiscal year 2004 earnings.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The Perrigo Company (NASDAQ:PRGO) announced results for the full year and fourth quarter ended June 26, 2004. Sales for the 12 months ended June 26, 2004, were $898.2 million, compared with $834.1...

Pharmaceutical company reports on events in fiscal year 2004.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Lannett Company, Inc., (LCI) reported on events that have occurred during its fiscal year ended June 30, 2004. On February 6, 2004, William Farber, the company's majority shareholder, entered into...

Stent maker discusses Q2, reports increased revenues.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Endologix, Inc., (ELGX), announced financial results for the second quarter ended June 30, 2004. Paul McCormick, Endologix's president and CEO, said, "During the second quarter, we continued to...

Urology-focused company reports fiscal fourth quarter and 2004 full-year results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Urologix, Inc. (ULGX), reported financial results for the fiscal fourth quarter and year ended June 30, 2004, and provided financial guidance for fiscal 2005. Fourth-quarter revenue rose 35% to...

Biopharmaceutical company receives delisting notice from Nasdaq.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Citing the postponement of the filing of VaxGen's financial statements for the fiscal quarters ended March 30 and June 30, 2004, which is due to the company implementing what it believes is a more...

CRO announces $2.0 million of new business contracts.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Commonwealth Biotechnologies, Inc., (CBTE) (CBI), a contract research organization (CRO), announced new contract work in two of its core business areas, biodefense and clinical lab trial support. ...

CRO awarded $9.7 million of new business with major biopharmaceutical company.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Covalent Group, Inc., (CVGR) announced that it was awarded $9.7 million of new business to provide full-service management and operational support of a clinical research program that includes an...

Company launches infusion therapy services to address a $5 billion market.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Health Sciences Group, Inc., (HESG), an integrated provider of science-based products and ingredients to customers in the nutrition, skin care, and food and beverage industries, announced that it...

Global research organization announces Center for Pricing and Reimbursement.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- MEDTAP International, Inc., announced PharmAnalysis Group, Inc., a provider of reimbursement planning for the pharmaceutical, biotechnology, medical device, and diagnostics industries, as MEDTAP's new...

Jenapharm's therapeutics business sold to Dermapharm AG.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Schering AG (SHR) announced that its German subsidiary, Jenapharm GmbH & Co. KG, Jena, has agreed to the sale of its therapeutics business to mibe Vertriebsgesellschaft mbH (i.G.), Jena, a subsidiary of...

Laredo Investment Corp announces name change.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Laredo Investment Corp (LRDI) has changed its company name to GFR Pharmaceuticals Inc., and has a new trading symbol (GFRP). This name change was made to better reflect the relationship with its...

Oral drug delivery technology supply agreement executed for chewable products.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- AXM Pharma, Inc., (AXJ) has executed an exclusive supply agreement for an oral drug delivery technology for chewable tablets, capsules, and lozenges from WN Pharmaceuticals Ltd. AXM Pharma acquired...

Pharmaceuticals company signs sales, marketing agreement with services provider.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Ventiv Health, Inc. (VTIV) announced that it has signed a sales and marketing agreement with Aventis Pharmaceuticals (AVE) that incorporates Ventiv's integrated services. Under the terms of the...

Pharmacy chain offers financing update.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Rite Aid Corporation (NYSE, PCX:RAD) announced that is has reached agreement with its lead banks, Citigroup Global Markets, Inc., and J.P. Morgan Securities, Inc., to replace its existing senior secured...

Systems biology company adds Bristol-Myers Squibb to customer base.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- GeneGo, Inc., announced that Bristol-Myers Squibb (BMS) has licensed its MetaCore data mining suite that combines analytical tools, data content, and algorithms for understanding complex interconnected...

Pharmaceutical company reports second quarter, clinical development results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Progenics Pharmaceuticals, Inc., (NASDAQ: PGNX) announced its results of operations for the second quarter ended June 30, 2004, and first half of 2004. The company also provided an update of its...

Spin-off company announces second quarter 2004 financial results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Pharmacopeia Drug Discovery, Inc., (NASDAQ:PCOP) announced results for the 3 and 6 months ended June 30, 2004. On April 30, 2004, the spin-off of Pharmacopeia Drug Discovery into an independent,...

Collaboration to develop orally active chloride channel blocker cancer therapy.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- TopoTarget A/S has entered into a collaboration with NeuroSearch (NEUR.CO) to develop the NeuroSearch compound Endovion (NS3728), an orally active chloride channel blocker for the treatment of cancer....

Pharma company reports financial results consistent with earlier guidance.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Onyx Pharmaceuticals, Inc., (NASDAQ:ONXX) reported a net loss of $13.1 million, or $0.38 per share, for the second quarter ended June 30, 2004, compared with a net loss of $11.4 million, or $0.48 per...

Pharmaceutical company announces third quarter financial results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- OSI Pharmaceuticals, Inc., (NASDAQ:OSIP) announced its financial results for the company's third quarter ended June 30, 2004. The company reported net losses for the third quarter and 9-month...

U.K. patient organizations recommends Glivec for inoperapeable tumors.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The National Institute for Clinical Excellence (NICE) concluded that Glivec (imatinib) should be prescribed in England and Wales, as a first-line option for all people with unresectable (inoperable)...

Binding patterns reveal tumor-specific epitope of epithelial mucin.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1). "Glycosylation determines essential biological functions of...

Plasmid DNA in microparticles stimulates durable T cell responses.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Repeated immunization with plasmid DNA formulated in poly(lactide-co-glycolide) microparticles is well tolerated and stimulates durable T cell responses to the tumor-associated antigen cytochrome...

Real-time myocardial border tracking for echocardiography is effective.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Real-time myocardial border tracking for echocardiography is effective. "Ultrasound is a main noninvasive modality for the assessment of the heart function. Wall tracking from ultrasound data is,...

Pennsylvania administration fails to approve nursing home rate increase.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- After learning that the Rendell Administration has decided to forego approval of a rate increase to help ensure Pennsylvania's nursing homes can continue providing quality care in the face of a severe...

Biotechnology added to drug watch list, settles patent litigation, names CEO.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Prana Biotechnology Limited (NASDAQ:PRAN) announced that Forbes.com has once again added Prana to it's list of "neurological drugs to watch," highlighting the most promising experimental drugs to treat...

DOV collaborates to develop and commercialize depression compounds.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Merck & Co., Inc., (MRK) and DOV Pharmaceutical, Inc., (DOVP) announced an agreement for the development and commercialization of DOV's triple uptake inhibitors being developed for depression and...

Pharmaceutical companies announce research extension of PDE4 collaboration.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Roche and Memory Pharmaceuticals Corp. (NASDAQ:MEMY) announced a 2-year extension of their PDE4 collaboration under their 2002 agreement. Under the extended agreement, Roche is committed to a...

Biosafety aspects of live oral Vibrio cholerae vaccine strain examined.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers examine the biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR in a recent issue of the journal Vaccine. "The development of live attenuated...

Annual meeting focused on high cholesterol guidelines and therapeutics.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Discussion about the science behind the recent changes to the National Cholesterol Education Program (NCEP) cholesterol-lowering guidelines and novel therapeutic approaches in the management of patients...

Collaboration set to discover biomarkers for COPD diagnostics, therapeutics.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- GenData Research Corporation and Battelle have entered into a collaboration for the discovery, development, and commercialization of biomarkers for diagnostic and therapeutic applications in chronic...

Research shows pharmaceutical companies stay lean through outsourcing.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A study by Cutting Edge Information finds leading pharmaceutical companies no longer use vendors just to meet demands their teams and plants cannot handle - they seek to "buy in" complete processes and...

Companies form alliance to develop SAP solutions for pharma, biotech firms.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Capgemini U.S. LLC has teamed with SAP to develop a rapidly deployable, fixed-price offering specifically for middle market pharmaceutical and biotech companies. FastPharma is Capgemini's...

Agreement signed for fourth generation LHRH antagonist D-63153.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- AEterna Zentaris, Inc., (AEZ; AEZS) announced that its German subsidiary Zentaris GmbH and Spectrum Pharmaceuticals, Inc., (SPPI) have entered into a licensing and collaboration agreement on a fourth...

Cisbio announces collaborations with reagent developers.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Cisbio international announced new business collaborations with two reagent suppliers, Cell Signaling Technology, Inc., (CST) and Upstate. These latest partnerships with well-established reagent...

CombiMatrix announces strategic microarray alliance.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Acacia Research Corp. (CBMX) announced that its CombiMatrix group has entered into a multiyear collaborative strategic alliance with Furuno Electric Co. The companies will design, engineer, and...